QT dispersion and heart rate variability abnormalities parallel disease progression in Alzheimer's disease and mild cognitive impairment, potentially serving as noninvasive predictors for cognitive decline and mortality.
Answers are grounded in this paper and cite their sources.
Does not support routine ECG monitoring in cognitive impairment; leaves open validation of QT dispersion and HRV as progression markers.
These findings support the presence of a peculiar neuroanatomic dysfunction in patients with AD and MCI that parallels the disease progression. These noninvasive parameters might prove to be powerful predictive tools in the worsening of cognitive function and mortality risk.
No takes yet. Share an insight, caveat, or question.
Zulli et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: